DownloadHi-Res Photo

Jennifer Ellen Miller, PhD

Associate Professor of Medicine (General Medicine); Director, Good Pharma Scorecard; Board President, Bioethics International; Advisory Board Member, Global Healthcare Innovation Management Center, Graduate School of Business; Yale Liaison, Working Group on: Bioethics of Data Science, Artificial Intelligence (AI) and Genomics Implementation Science Curriculum; Expanded Access Program for Experimental Covid19 Drugs, Ethics Committee

Biography
Research & Publications
News

DownloadHi-Res Photo

Appointments

General Internal Medicine

Biography

Jennifer E. Miller, PhD, is an Associate Professor in Yale School of Medicine; Director of the Good Pharma Scorecard (an index that ranks pharmaceutical companies on their bioethical performance); and Founder of the nonprofit Bioethics International.

Her current research focuses on ethics, equity and governance in drug, vaccine and medical device research, development, and delivery as well as in healthcare data sharing. She also specializes in developing and using metrics to enhance accountability and social responsibility in biomedical innovation.

Prior to joining Yale’s faculty, she was an Assistant Professor (tenure track) in NYU School of Medicine and completed training in physics, regulatory governance, bioethics, and ethics at Fordham University, Duke University, Regina Apostolorum Pontifical University, and Harvard University.

Education & Training

Non Degree Program
Harvard University, Ethics (2015)
Postdoctoral Fellowship
Duke University (2015)
PhD
Regina Apostolorum Pontifical University, Bioethics (2015)
Postdoctoral Fellowship
Harvard University (2014)
BS
Fordham University, Physics (2002)

Activities

Pharmaceutical Industry Ethics and The Good Pharma Scorecard
New York, NY, United States 2020
Pharmaceutical Industry Ethics and The Good Pharma Scorecard
What Makes Medical Data Sharing Ethical?
New York, NY, United States 2020
What Makes Medical Data Sharing Ethical?
Clinical Trial Transparency and Data Sharing
Broadstairs, England, United Kingdom 2020
Clinical Trial Transparency and Data Sharing
Panel on Genomic Medicine Ethics
San Diego, CA, United States 2020
Panel on Genomic Medicine Ethics
EHR Data Sharing: What Makes Data Sharing Ethical?
Philadelphia, PA, United States 2020
EHR Data Sharing: What Makes Data Sharing Ethical?
Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
Ottawa, ON, Canada 2020
Transparency and Data Sharing in Clinical Trials: Ethics Standards and the Role of the Good Pharma Scorecard
Bioethics and Controversial Trends in Healthcare Innovation
New York, NY, United States 2020
Bioethics and Controversial Trends in Healthcare Innovation
Responsible Data Sharing in Medicine and Clinical Research
Montreal, QC, Canada 2020
Responsible Data Sharing in Medicine and Clinical Research
Non-Trial Preapproval Access to Investigational Medical Products
New York, NY, United States 2020
Non-Trial Preapproval Access to Investigational Medical Products
Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
Coral Gables, FL, United States 2020
Discuss Ethical Standards for Clinical Research and the Responsibilities of the Life Sciences Industry
Oral Presentation
Philadelphia, PA, United States 2020
Oral Presentation
Global Health Justice and Access to Medicines
Binghamton, NY, United States 2020
Global Health Justice and Access to Medicines
Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
Cambridge, MA, United States 2019
Transparency in Health and Healthcare in the United States, Panel Presentation: Transparency and Data sharing in the Pharmaceutical Industry
Ethics of Clinical Trials and Data Privacy
Jerusalem, Jerusalem District, Israel 2019
Ethics of Clinical Trials and Data Privacy
Access to Emerging Therapies for Genetic Disorders
Rochester, NY, United States 2019
Access to Emerging Therapies for Genetic Disorders
Responsible Clinical Trial Transparency and Data Sharing
Philadelphia, PA, United States 2019
Responsible Clinical Trial Transparency and Data Sharing
Responsible Data Sharing
Philadelphia, PA, United States 2019
Responsible Data Sharing
Brain Health and Performance Summit, Whose Data are They?
Columbus, OH, United States 2019
Brain Health and Performance Summit, Whose Data are They?
Inaugural Councils Meeting
San Francisco, CA, United States 2019
Inaugural Councils Meeting
Progress Towards the Sustainable Development Goals
Princeton, NJ, United States 2019
Progress Towards the Sustainable Development Goals
Ethics of Data-Sharing in Digital Medicine
Boston, MA, United States 2019
Ethics of Data-Sharing in Digital Medicine
Roundtable on Data-Sharing in Medicine
Los Angeles, CA, United States 2019
Roundtable on Data-Sharing in Medicine
Ethics of Big Data and AI in Radiology
New York, NY, United States 2019
Ethics of Big Data and AI in Radiology
Social Responsibility in Pharma
Philadelphia, PA, United States 2019
Social Responsibility in Pharma
Breaking Barriers to Health Data Governance
San Francisco, CA, United States 2019
Breaking Barriers to Health Data Governance
Ethics of Federated Models
San Francisco, CA, United States 2019
Ethics of Federated Models
Solutions Approach to Data Privacy and Ethics
Washington, DC, United States 2019
Solutions Approach to Data Privacy and Ethics
Establishing a Pharma Code of Ethics
Barcelona, CT, Spain 2019
Establishing a Pharma Code of Ethics
Preventing the Cambridge Analytica of Health Data
Austin, TX, United States 2019
Preventing the Cambridge Analytica of Health Data
Data-sharing Principles in Medicine
Bethesda, MD, United States 2019
Data-sharing Principles in Medicine
Ethics of Emerging Biotechnologies
Dubai, Dubai, United Arab Emirates 2018
Ethics of Emerging Biotechnologies
The Ethics of Big Data in Healthcare. October 24, 2018
New York, NY, United States 2018
Opening Keynote: The Ethics of Big Data in Healthcare. October 24, 2018
The Future of Health Summit, Panel on Innovation
Los Angeles, CA, United States 2018
The Future of Health Summit, Panel on Innovation
Measuring Impact in Patient-Centered Drug Development
Bethesda, MD, United States 2018
Measuring Impact in Patient-Centered Drug Development
Blockchain as Pharma's Trust Catalyst
Madrid, Community of Madrid, Spain 2018
Blockchain as Pharma's Trust Catalyst
Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
London, England, United Kingdom 2018
Deconstructing Clinical Trials: The Core of Drug Development and Company Valuations
Ethics and Trust in Healthcare Innovation
New York, NY, United States 2018
Keynote, Ethics and Trust in Healthcare Innovation
Research Ethics Workshop
New York, NY, United States 2018
Research Ethics Workshop
Promise and Reality of Clinical Trial Transparency and Data-sharing
London, England, United Kingdom 2018
Promise and Reality of Clinical Trial Transparency and Data-sharing
Ethics and Governance and Healthcare Innovation
New York, NY, United States 2018
Ethics and Governance and Healthcare Innovation
Clinical Trial Transparency and Data-sharing in Healthcare Innovation
New York, NY, United States 2018
Clinical Trial Transparency and Data-sharing in Healthcare Innovation
Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
Baltimore, MD, United States 2018
Drug Accessibility and Pricing Symposium: Preserving Consumer Access in the Complex Pharmaceuticals Marketplace
Big Data and Ethics
New York, NY, United States 2018
Big Data and Ethics
Ethics of Big Data, Machine Learning and AI
New York, NY, United States 2018
Ethics of Big Data, Machine Learning and AI
Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
Philadelphia, PA, United States 2018
Elevate Organizational and New Drug Clinical Trial Transparency Best Practices
Lecture on Pharmaceutical Ethics
Augusta, GA, United States 2017
Lecture on Pharmaceutical Ethics
Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
Augusta, GA, United States 2017
Ethics, Transparency and Trust in Pharma and the Role of the Good Pharma Scorecard
Augmented Humans: Are Super Humans the New Reality?
Dubai, Dubai, United Arab Emirates 2017
Augmented Humans: Are Super Humans the New Reality?
Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
New York, NY, United States 2017
Cybersecurity’s Accelerating Threat: The Impact of Evolving Technologies
Returning Lay Summaries to Trial Participants
Philadelphia, PA, United States 2017
Returning Lay Summaries to Trial Participants
Data-Sharing: Do We Measure Up?
Rockville, MD, United States 2017
Data-Sharing: Do We Measure Up?
The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
New York, NY, United States 2017
The Need to Accelerate Therapeutic Development — Must Randomized Controlled Trials Give Way?
Transparency in Healthcare
Cambridge, MA, United States 2017
Transparency in Healthcare
The Intersecting Worlds of Researchers, Executives and Journalists
Greencastle, IN, United States 2017
The Intersecting Worlds of Researchers, Executives and Journalists
Ethics and Trust in the Pharmaceutical Industry
New York, NY, United States 2017
Ethics and Trust in the Pharmaceutical Industry
Cyber Security
New York, NY, United States 2017
Cyber Security
Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
New Brunswick, NJ, United States 2017
Clinical Trial Transparency, Data-sharing, and the Good Pharma Scorecard
Healthcare Innovation Ethics
New York, NY, United States 2017
Healthcare Innovation Ethics
Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
London, England, United Kingdom 2017
Clinical Data Disclosure and Transparency: Navigate Global Regulations, Data Sharing and Trial Registries, Explore Ethics and The Good Pharma Scorecard
Access, Value, and Trust in Healthcare Innovation
Newport Beach, CA, United States 2017
Access, Value, and Trust in Healthcare Innovation
Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
New York, NY, United States 2016
Clinical Trial Transparency, Drug Development, and the Good Pharma Scorecard
Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
Basel, BS, Switzerland 2016
Clinical Trial Transparency and Regulation Conference, Clinical Trial Data Sharing: Status & Benchmarking—Good Pharma Scorecard
Ethics and Trust in Healthcare Innovation
Palo Alto, CA, United States 2016
Ethics and Trust in Healthcare Innovation
Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
Newark, NJ, United States 2016
Workshop on Ethical Issues in Marketing Pharmaceuticals in Emerging Health Systems
Working Together to Serve Patients
New York, NY, United States 2016
Working Together to Serve Patients
Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
New York, NY, United States 2016
Caring for Vulnerable Populations: Cognitive Assessment, Ethical Considerations, and Health Policy
Ethics and Transparency in Healthcare Innovation
Philadelphia, PA, United States 2016
Ethics and Transparency in Healthcare Innovation
The Good Pharma Scorecard: Special Focus on Publications
Tarrytown, NY, United States 2016
The Good Pharma Scorecard: Special Focus on Publications
Ethical Issues in Clinical Research
New York, NY, United States 2016
Ethical Issues in Clinical Research
Pharmaceutical Strategy: Ethics and Reputational Hazards
New York, NY, United States 2016
Pharmaceutical Strategy: Ethics and Reputational Hazards
Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
New York, NY, United States 2016
Ethics and Governance of Healthcare Innovation and the Good Pharma Scorecard
Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
New York, NY, United States 2016
Critical Issues in Emergency Medicine Antidotes in Society: Ethics, Capital, Regulation, Scientific Principle, Public Health, and the Public Good
Institutional Corruption in Medicine and Healthcare Innovation: Concerns, Benchmarks, and a Roadmap for Trustworthy Reform
Washington, DC, United States 2016
Institutional Corruption and Medicine
Institutional Corruption and Medicine
Chattanooga, TN, United States 2016
Institutional Corruption and Medicine
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
New York, NY, United States 2015
Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012
Lecture
New York, NY, United States 2015
Lecture
Research Spotlight Presentation
New York, NY, United States 2015
Research Spotlight Presentation
Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
Baltimore, MD, United States 2015
Ethics and Trust in Healthcare Innovation: Could Ranking Pharmaceutical Companies and New Drugs on Clinical Trial Transparency Help?
Transparency and Data Sharing Roundtable
Cambridge, MA, United States 2015
Transparency and Data Sharing Roundtable
Promises and Pitfalls of our Clinical Research System
New York, NY, United States 2015
Lecture
The Ethics of Healthcare Innovation
New York, NY, United States 2015
The Ethics of Healthcare Innovation
Lecture
London, England, United Kingdom 2015
Lecture
Lecture
Binghamton, NY, United States 2015
Lecture
Institutional Corruption in Medicine
Cambridge, MA, United States 2015
Institutional Corruption in Medicine
Research Ethics
New York, NY, United States 2015
Research Ethics
Ethics, Trust, Global Health and the Pharmaceutical Industry
Cambridge, MA, United States 2015
Ethics, Trust, Global Health and the Pharmaceutical Industry
Lecture
Binghamton, NY, United States 2015
Lecture
Bioethics and Trust in the Industry– Could Rating Help?
Cambridge, MA, United States 2015
Bioethics and Trust in the Industry– Could Rating Help?
Ethics, Trust, Global Health and the Pharmaceutical Industry
Durham, NC, United States 2015
Ethics, Trust, Global Health and the Pharmaceutical Industry
Shining Light on Healthcare Innovation
Durham, NC, United States 2015
Shining Light on Healthcare Innovation
Data-sharing in Clinical Trials
Cambridge, MA, United States 2015
Data-sharing in Clinical Trials
Combatting Institutional Corruption in Medicine with the Open Pharma Index
Cambridge, MA, United States 2015
Institutional Corruption in Medicine
Ethics, Human Rights and the Pharmaceutical Industry
Durham, CT, United States 2015
Ethics, Human Rights and Business
Transparency and Ethics in Healthcare Innovation
Newark, NJ, United States 2015
Transparency and Ethics in Healthcare Innovation
Compassionate Use and Pre-Approval Access to Experimental Drugs
New York, NY, United States 2015
Compassionate Use and Pre-Approval Access to Experimental Drugs
Ethics, Human Rights and the Pharmaceutical Industry
Durham, NC, United States 2015
Ethics, Human Rights and the Pharmaceutical Industry
Transparency and Ethics in Healthcare Innovation
Newark, NJ, United States 2015
Transparency and Ethics in Healthcare Innovation
Corruption, Ethics and Governance in Biomedical Research
Durham, NC, United States 2014
Corruption, Ethics and Governance in Biomedical Research
Adaptive Regulatory Strategies in Healthcare Innovation
Durham, NC, United States 2014
Adaptive Regulatory Strategies in Healthcare Innovation
Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
Cambridge, MA, United States 2014
Transparency and Trust in the Pharmaceutical Industry: Could Rating Help?
Ethics in the Pharmaceutical Industry: Could Rating Help?
New York, NY, United States 2014
Ethics in the Pharmaceutical Industry: Could Rating Help?
Bioethics and Trust in the Industry– Could Rating Help?
Cambridge, MA, United States 2014
Bioethics and Trust in the Industry– Could Rating Help?
Ethics and Trust in the Pharmaceutical Industry
Mexico City, CDMX, Mexico 2014
Ethics and Trust in the Pharmaceutical Industry
Truth-telling and the Pharmaceutical Industry
New York, NY, United States 2014
Truth-telling and the Pharmaceutical Industry
Institutional Corruption in Big Pharma
Cambridge, MA, United States 2014
Institutional Corruption in Big Pharma
Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
Cambridge, MA, United States 2014
Pharmaceutical Ethics: Industry Perspectives and a Strategy for Trustworthy Reform
Ethical Standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
Pittsburgh, PA, United States 2014
Ethical standards in the Pharmaceutical Industry? Problems and a Strategy for Trustworthy Reform
Companies’ Global Health Footprint: Could Rating Help?
Cambridge, MA, United States 2013
Companies’ Global Health Footprint: Could Rating Help?
Globalization and the Market
New York, NY, United States 2013
Globalization and the Market
Public Health Ethics
Washington, DC, United States 2013
Public Health Ethics
Bioethics and Trust in the Industry
Cambridge, MA, United States 2013
Bioethics and Trust in the Industry
Bioethics and Trust in the Industry
Cambridge, MA, United States 2013
Bioethics and Trust in the Industry
Ethical Standards in the Pharmaceutical Industry?
New York, NY, United States 2013
Ethical Standards in the Pharmaceutical Industry?
Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
Amherst, MA, United States 2013
Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
Blinding Science: Blinding as a Solution to Institutional Corruption
Cambridge, MA, United States 2013
Blinding Science: Blinding as a Solution to Institutional Corruption
Institutional Corruption and Health Care: Ethical Standards in the Pharmaceutical Industry? Concerns, Industry Perspectives, and a Strategy for Trustworthy Reform
Boston, MA, United States 2013
Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
Boston, MA, United States 2013
Power, Privilege and the Pursuit of Justice: Legal Challenges in Precarious Times
Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
Cambridge, MA, United States 2012
Ethical Standards in the Pharmaceutical Industry? Industry Perspectives and Reform Strategies
Pharmaceutical Ethics
New York, NY, United States 2012
Pharmaceutical Ethics
The Ethics of Drug Development and Marketing
New York, NY, United States 2012
The Ethics of Drug Development and Marketing
Ethical Standards for the Pharmaceutical Industry?
Jersey City, NJ, United States 2012
Ethical Standards for the Pharmaceutical Industry?
Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes
New Orleans, LA, United States 2012
Why Corruption is Harder to Resolve Than You Think: Lessons from the Politics of Regulatory Regimes, January 14, 2012
The Role of Virtue in Medicine,
Chicago, IL, United States 2011
The Role of Virtue in Medicine,
Ethical Issues in Pediatric Emergency Mass Critical Care
Bangkok, Bangkok, Thailand 2011
Ethical Issues in Pediatric Emergency Mass Critical Care
Introduction to Bioethical Frameworks
Bangkok, Bangkok, Thailand 2011
Introduction to Bioethical Frameworks
Bioethical Issues in the Globalization of Clinical Research
Albany, NY, United States 2011
Bioethical Issues in the Globalization of Clinical Research
Pharmaceutical Ethics
Durham, NC, United States 2011
Pharmaceutical Ethics
Genomics, Ethics and Industry Practice
Burnaby, BC, Canada 2011
Genomics, Ethics and Industry Practice
Medical Diplomacy: Response to Environmental Disasters
New York, NY, United States 2011
Medical Diplomacy: Response to Environmental Disasters
Ethical Concerns in Biotechnology and Health Care Advances
Washington, DC, United States 2011
Ethical Concerns in Biotechnology and Health Care Advances
Next Steps for the Princeton University Open Hearts Initiative
New Orleans, LA, United States 2011
Next Steps for the Princeton University Open Hearts Initiative
Disaster Medicine
New York, NY, United States 2010
Disaster Medicine
15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-Third Special Session of the General Assembly (2000)
New York, NY, United States 2010
15-year Review of the Implementation of the Beijing Declaration and Platform for Action (1995) and the Outcomes of the Twenty-third Special Session of the General Assembly (2000)
Lecture
Tampa, FL, United States 2010
Lecture
Lecture
Erie, PA, United States 2010
Lecture
Finding Common Ground
Princeton, NJ, United States 2010
Debate
Is Common Ground Possible?
Princeton, NJ, United States 2010
Is Common Ground Possible?
Who Should be Responsible for Tomorrow’s Drugs?
San Diego, CA, United States 2010
Who Should be Responsible for Tomorrow’s Drugs?
Introduction to Ethical Frameworks and Clinical Decision-Making
New York, NY, United States 2009
Introduction to Ethical Frameworks and Clinical Decision-Making
Climate Change, Public Health and Emergency Preparedness,
New York, NY, United States 2009
Climate Change, Public Health and Emergency Preparedness,
Biotechnology in 20 Years: Privatization and Ethical Considerations
New York, NY, United States 2008
Biotechnology in 20 Years: Privatization and Ethical Considerations
Balancing Autonomy and Community in Promotion of Human Dignity
New York, NY, United States 2008
Balancing Autonomy and Community in Promotion of Human Dignity
New Dilemmas in Modern Medicine
New York, NY, United States 2008
New Dilemmas in Modern Medicine
Ethics of Pandemic Decision-making and Allocation of Medical Resources
Erie, PA, United States 2008
Ethics of Pandemic Decision-making and Allocation of Medical Resources
Ethical Frameworks and Disaster Preparedness
Erie, PA, United States 2008
Ethical Frameworks and Disaster Preparedness
New Ethical Dilemmas in Medicine
New York, NY, United States 2008
New Ethical Dilemmas in Medicine
Bioethical Frameworks and Pandemic Preparedness
New York, NY, United States 2007
Bioethical Frameworks and Pandemic Preparedness
Did I Hasten My Patient’s Death?
Bridgeport, CT, United States 2007
Did I Hasten My Patient’s Death?
Lecture
Bridgeport, CT, United States 2007
-
Lecture
Bridgeport, CT, United States 2007
Lecture
Grand Rounds Lecture
Bridgeport, CT, United States 2007
Grand Rounds Lecture
Ethics of Adoption and Freezing of Embryos and Natural Law
New York, NY, United States 2005
Ethics of Adoption and Freezing of Embryos and Natural Law
Stem Cell Research Ethics, Course Lecture for Philosophical Ethics
New York, NY, United States 2002
Stem Cell Research Ethics, Course Lecture for Philosophical Ethics

Honors & Recognition

Award	Awarding Organization	Date
Center for the Fourth Industrial Revolution, Precision Medicine Council	Appointment to World Economic Forum	2019
Biotechnology Council	Appointment to World Economic Forum	2018
Futures Council	Appointment to World Economic Forum	2017
Human Enhancement Working Group	Appointment to World Economic Forum	2017
Ethical Issues in Global Population Health, Foundation Brocher	Fellow	2014
United Nations Educational Social and Cultural Organization (UNESCO) Global Ethics Observatory	Appointed	2009

Professional Service

Organization	Role	Date
Present Working Group Member, Consortia for Improving Medicine with Innovation and Technology (CIMIT), Yale University (NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2) directed at Yale by Michael K. Dempsey & at Harvard by Steven Schachter	NIH-funded U54 Coordinating Center, focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter	2020
Yale Pediatric Nephrology Residents Research Ethics Lecture (March 27, 2020)	Lecturer	2020
Yale Data Day, Cushing Whitney Medical Library Class: "Data and Privacy: Day of Data Series Panel Discussion, Yale Medical School Library (February 13, 2020)	Participant	2020
Yale Center For Clinical Investigation (YCCI), NCATS Clinical Translational Science Award (CTSA), Mount Sinai Curriculum for Bioethics Training in Data Science and AI	Lead	2020 - Present
Present Yale Equity Research and Innovation Center (ERIC), Covid Disparities Working Group	Member	2020 - Present
Consortia for Improving Medicine with Innovation and Technology (CIMIT), NIH-funded U54 Coordinating Center	NIH-funded U54 Coordinating Center focused on point of care testing SARS-CoV-2, national effort coordinated through NIH, directed at Yale by Michael K. Dempsey and at Harvard by Steven Schachter	2020 - Present
Alexion Pharmaceuticals Ethics Committee, Expanded Access Program for Covid-Related Drugs and ALS Program	Committee Member	2020 - Present
Scientific American, Science for Good	Editor	2020 - Present
Expanded Access Program for Covid-Related Drugs and ALS Program, Ethics Committee, Alexion Pharmaceuticals	Committee Member	2020 - Present
Committee on Standards for Data Collection and Use, IEEE	Advisor	2019 - 2020
Yale Law School Health Data Workshop Co-Chair with Chris Morten, Joe Ross, Jen Pinsoff, Amy Kapczynski	Co-Chair	2019
Yale Digital Medicine Symposium, Ethical Considerations in Digital Medicine, April 26, 2019	Presenter/Speaker	2019
Nature Medicine	Reviewer	2019 - Present
BMC Medicine	Reviewer	2019 - Present
The Journal of Bioethics	Reviewer	2019 - Present
Yale Law School, Center for Research and Integrity	Member	2018 - 2019
Yale Law School MFIA Clinic, Data-Sharing in Medicine, Supervisor	Lead	2018 - 2019
Director’s Working Group on Ethical Considerations for Industry Partnership on Research to Help End the Opioid Crisis, NIH	Committee Member	2018
New England Journal of Medicine (NEJM)	Reviewer	2018 - Present
The British Medical Journal (BMJ)	Reviewer	2018 - Present
World Economic Forum	Member	2017 - Present
New York University (NYU) School of Medicine, Pharmacy and Therapeutics Committee	Committee Member	2016 - 2019
The Journal of the American Medical Association (JAMA) Internal Medicine	Reviewer	2016 - Present
Pharmacy and Therapeutics Committee, NYU School of Medicine	Committee Member	2016 - Present
NYU Electronic Medical Records (EMR) Working Group, New York University	Tasked with developing new guidelines for incorporating clinical research into Epic	2016 - Present
Institutional Review Board, Embryonic Stem Cell Research Oversight, New York University (NYU) School of Medicine	Committee Member	2015 - 2019
Compassionate Use and Expanded Access Committee, Johnson and Johnson (J&J) and New NYU School of Medicine	Scientific Advisor	2015 - 2017
Journal of Evidence-based Medicine & Public Health	Editor	2015 - 2016
Committee on Data Sharing and Transparency, Harvard University Multi-Regional Clinical Trials Initiative	Board Member	2015 - 2016
Advanced Disaster Life Support (ADLS®)	Ethical and Legal Considerations (Chapter 5), Advanced Disaster Life Support (ADLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer)	2015
Core Disaster Life Support (CDLS®)	Legal and Ethical Issues (Chapter 5), Core Disaster Life Support (CDLS®) Course Manual, Version 3.0, American Medical Association (Miller, J. Advisor and Reviewer)	2015
Journal of Clinical Pharmacology	Reviewer	2015 - Present
Stem Cells Translation Medicine	Reviewer	2015 - Present
Embryonic Stem Cell Research Oversight Committee, NYU School of Medicine	Committee Member	2015 - Present
Pragmatic Clinical Trials Initiative, Gatekeepers Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network	Board Member	2014 - 2015
Pragmatic Clinical Trials Initiative, Vulnerable Subjects Workgroup, PCORI-NIH Collaboratory and National Patient-Centered Clinical Research Network	Board Member	2014 - 2015
Public Library of Science (PLOS ONE)	Reviewer	2014 - Present
Criteria for Data Sharing Subgroup, Harvard University Multi-Regional Clinical Trials Initiative	Co-Chair	2013 - 2014
Pharmaceutical Regulatory Affairs: Open Access, OMICS Publishing Group	Reviewer	2013 - Present
Law and Society Association, Institutional Corruption	Committee Member	2012 - 2015
Ethics Committee, Harvard University Multi-Regional Clinical Trials Initiative	Committee Member	2012 - 2014
American Society of Bioethics and Humanities	Member	2012 - Present
Center for Policy and Emerging Technologies, Advisory Board	Board Member	2010 - 2015
Center for Policy and Emerging Technologies, Center for Policy and Emerging Technologies	Advisor	2010 - 2015
Advisory Board, Center for Policy and Emerging Technologies	Advisor	2010 - 2015
Ethics Committee and IRB Workshop Director, Tampa General Hospital, Morsani College of Medicine, University of South Florida	Director	2010
Pediatric Emergency Mass Critical Care Taskforce, Steering Committee, Centers for Disease Control and Prevention (CDC)	Committee Member	2009 - 2011
Pediatric Emergency Mass Critical Care Taskforce, Ethics Committee, Centers for Disease Control and Prevention (CDC)	Committee Member	2009 - 2011
Pandemic and Emergency Preparedness Ethics Grand Rounds Director, St. Vincent’s Health System (Pennsylvania)	Director	2008
Pandemic and Emergency Preparedness Ethics Grand Rounds Director for the Department of Emergency Medicine, Hamot Hospital (Pennsylvania)	Director	2008
American Medical Association, National Disaster Life Support Education Consortium	Member	2007 - 2011
American Museum of Natural History, Junior Advisory Council	Council Member	2007 - 2011
ICU Rounds on End of Life Care Ethics, St. Vincent’s Medical Center (Connecticut)	Lecturer	2007
Medical Ethics Lecturer for Radiology and Transitional Year Residency Program, St. Vincent’s Medical Center (Connecticut)	Lecturer	2007
Medical Ethics Lecturer for Internal Medicine Department, St. Vincent’s Medical Center (Connecticut)	Lecturer	2007
Pandemic and Emergency Preparedness Ethics Hospital-Wide Grand Rounds, St. Vincent’s Medical Center (Connecticut)	Lecturer	2007
Bioethics International	President	2006 - Present
Bioethics International	Board Member	2005 - Present
Bellevue Hospital, High School Pediatric Psychiatric Ward Volunteers, Volunteer Director	Director	2004 - 2006

Departments & Organizations

Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT)
General Internal Medicine
Internal Medicine
Program for Biomedical Ethics
Yale Center for Genomic Health

Edit Profile

Jennifer Ellen Miller, PhD

Contact Information

Mailing Address

Biography

Research & Publications

News

Appointments

Biography

Education & Training

Activities

Honors & Recognition

Professional Service

Departments & Organizations